Literature DB >> 34142808

Catalytically Active CoFe2O4 Nanoflowers for Augmented Sonodynamic and Chemodynamic Combination Therapy with Elicitation of Robust Immune Response.

Shiyan Fu1,2, Ruihao Yang1, Junjie Ren1, Jiahui Liu1, Lei Zhang3, Zhigang Xu1, Yuejun Kang1, Peng Xue1.   

Abstract

A hypoxic and acidic tumor microenvironment (TME) plays a significant role in cancer development through complex cellular signaling networks, and it is thus challenging to completely eradicate tumors via monotherapy. Here, PEGylated CoFe2O4 nanoflowers (CFP) with multiple enzymatic activities, serving as bioreactors responsive to TME cues, were synthesized via a typical solvothermal method for augmented sonodynamic therapy (SDT) and chemodynamic therapy (CDT) with elicitation of robust immune response. The CFP occupying multivalent elements (Co2+/3+, Fe2+/3+) exhibited strong Fenton-like and catalase-like activity. In another aspect, CFP itself is a brand-new sonosensitizer for high-performance SDT based on ultrasound-triggered electron (e-)/hole (h+) pair separation from the energy band with promptness and high efficiency. With efficient enrichment in tumorous tissue as revealed by magnetic resonance imaging, CPF could generate •OH for CDT relying on Fenton-like reactions. Moreover, catalase-mimicking CFP could react with endogenous H2O2 to generate molecular oxygen, and high O2 level may promote the production of 1O2 for SDT. What's more, the reactive oxygen species obtained from combined SDT/CDT could efficiently trigger immunogenic cell death through a synergistic therapy based on the elicitation of antitumor immunity with the aid of an immune checkpoint blockade for the sake of suppressing primary and distant tumors as well as lung metastasis. Taken together, this paradigm delivers useful insights for developing in-coming nanocomposites based on cobalt ferrite for cancer theranostics.

Entities:  

Keywords:  chemodynamic therapy; cobalt ferrite; immune activation; sonodynamic therapy; tumor microenvironment

Year:  2021        PMID: 34142808     DOI: 10.1021/acsnano.1c03128

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  11 in total

Review 1.  Research Progress on Improving the Efficiency of CDT by Exacerbating Tumor Acidification.

Authors:  Wenting Chen; Jinxi Liu; Caiyun Zheng; Que Bai; Qian Gao; Yanni Zhang; Kai Dong; Tingli Lu
Journal:  Int J Nanomedicine       Date:  2022-06-10

2.  Defect engineering of layered double hydroxide nanosheets as inorganic photosensitizers for NIR-III photodynamic cancer therapy.

Authors:  Weicheng Shen; Tingting Hu; Xueyan Liu; Jiajia Zha; Fanqi Meng; Zhikang Wu; Zhuolin Cui; Yu Yang; Hai Li; Qinghua Zhang; Lin Gu; Ruizheng Liang; Chaoliang Tan
Journal:  Nat Commun       Date:  2022-06-13       Impact factor: 17.694

Review 3.  Recent advances of cancer chemodynamic therapy based on Fenton/Fenton-like chemistry.

Authors:  Changyu Cao; Xiaorui Wang; Nan Yang; Xuejiao Song; Xiaochen Dong
Journal:  Chem Sci       Date:  2021-11-29       Impact factor: 9.825

Review 4.  Fenton/Fenton-like metal-based nanomaterials combine with oxidase for synergistic tumor therapy.

Authors:  Wei Cao; Mengyao Jin; Kang Yang; Bo Chen; Maoming Xiong; Xiang Li; Guodong Cao
Journal:  J Nanobiotechnology       Date:  2021-10-16       Impact factor: 10.435

Review 5.  Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications.

Authors:  Lianxiang Luo; Han Wang; Wen Tian; Xiaoling Li; Zheng Zhu; Riming Huang; Hui Luo
Journal:  Theranostics       Date:  2021-10-22       Impact factor: 11.556

Review 6.  Stimuli-Responsive Drug Delivery Systems for the Diagnosis and Therapy of Lung Cancer.

Authors:  Xu Lin; Jiahe Wu; Yupeng Liu; Nengming Lin; Jian Hu; Bo Zhang
Journal:  Molecules       Date:  2022-01-30       Impact factor: 4.411

7.  Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy.

Authors:  Jiong Li; Sijia Wang; Xinyi Lin; Yanbing Cao; Zhixiong Cai; Jing Wang; Zhenxi Zhang; Xiaolong Liu; Ming Wu; Cuiping Yao
Journal:  Nanomicro Lett       Date:  2022-02-05

8.  Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma.

Authors:  Liwen Fu; Weiying Zhang; Xiaojun Zhou; Jingzhong Fu; Chuanglong He
Journal:  Bioact Mater       Date:  2022-01-26

Review 9.  Application of nanosonosensitizer materials in cancer sono-dynamic therapy.

Authors:  Chaotao Hu; Biao Hou; Songlin Xie
Journal:  RSC Adv       Date:  2022-08-15       Impact factor: 4.036

Review 10.  Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications.

Authors:  Nem Singh; Jungryun Kim; Jaewon Kim; Kyungwoo Lee; Zehra Zunbul; Injun Lee; Eunji Kim; Sung-Gil Chi; Jong Seung Kim
Journal:  Bioact Mater       Date:  2022-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.